Vanderbilt University: Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial -December 05, 2023 at 05:30 am EST

A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical...

Related Keywords

,Williamk Warren Jr ,Aaron Bender ,Robert Lenz ,Daniel Diermeier ,Olivier Boutaud ,Colleen Niswender ,Kayla Temple ,P Jeffrey Conn ,Alison Gregro ,Carrie Jones ,Padma Raghavan ,Craig Lindsley ,Vice Provost For Research ,Williamk Warren Foundation ,Warren Center ,Neumora Therapeutics Inc ,University Professor ,Drug Administration ,National Institutes Of Health ,Neuroscience Drug Discovery ,Director Emeritus ,Jeffrey Conn ,Investigational New Drug ,Therapeutics Inc ,Homer Style Odyssey ,Vice Provost ,Technology Transfer ,News Publishing ,Markets ,